Heart Failure with Targeted Cancer Therapies: Mechanisms and Cardioprotection

Keyphrases

• Targeted Therapy 100%
• Heart Failure 100%
• Cardioprotection 100%
• Targeted Cancer Therapy 100%
• Therapy Mechanism 100%
• Mitogen-activated Protein Kinase 33%
• Cell-to-cell 33%
• Progression-free Survival 33%
• Cancer Types 33%
• Signaling Pathway 33%
• Overall Survival 33%
• Human Epidermal Growth Factor Receptor 2 (HER2) 33%
• Cancer Cells 33%
• Multiple Cell Types 33%
• Viral Oncogenes 33%
• Oncologic 33%
• Tyrosine Kinase Inhibitor 33%
• Protease Inhibitors 33%
• Immune Checkpoint Inhibitors 33%
• Long-term Treatment 33%
• Sarcoma 33%
• Oncology 33%
• Cardiotoxicity 33%
• Cardiovascular Toxicity 33%
• Systemic Toxicity 33%
• Androgen Deprivation Therapy 33%
• Toxicity Management 33%
• Cardioprotective Strategies 33%
• Heart Failure Incidence 33%
• Non-cancer Cell 33%

Medicine and Dentistry

• Targeted Therapy 100%
• Congestive Heart Failure 100%
• Heart Protection 100%
• Molecularly Targeted Therapy 100%
• Progression Free Survival 33%
• Cancer Cell 33%
• Cancer Types 33%
• Overall Survival 33%
• Epidermal Growth Factor Receptor 2 33%
• Gamma Urogastrone 33%
• Oncology 33%
• Immune Checkpoint Inhibitor 33%
• Cell Signaling Pathway 33%
• Cardiotoxicity 33%
• Proteasome Inhibitor 33%
• Tyrosine-Kinase Inhibitor 33%
• Androgen Deprivation Therapy 33%
• Virus Oncogene 33%
• Cardiovascular Toxicity 33%
• B Raf Kinase 33%
• Mitogen Activated Protein Kinase Kinase 33%
• Connective Tissue Cancer 33%